Medication for Hiccups

Centrally acting medicinal products in the treatment of persistent hiccups are copper (as a metal that warms through and promotes relaxation) and herbal preparations from the nightshade family, especially Nicotiana tabacum (acting as an antispasmodic) and Hyoscyamus niger (which encourages rhythm and calming):

Aurum/Hyoscyamus comp. WELEDA
or 
Cuprum aceticum comp. WALA
or 
Cuprum aceticum D4 WELEDA, 1 amp. s.c. over the epigastrium
or
Cuprum aceticum D5/Zincum Valerianicum D5 WELEDA, 1 amp. s.c., 1 to several times daily

Also to be considered is:
Tabacum Cupro cultum Rh D3 WELEDA, 1 amp. s.c. in the epigastrium

To increase the effectiveness of the injections, combine with:
Nervus phrenicus D15–D30 WALA, 1 amp. s.c. 3x/w to 1x/d

Possible orals are: 
Hyoscyamus Rh D3 dil. WELEDA, 10 drops 3x/d
or
Hyoscyamus D6 pill. WALA, 7 pill. every 1–2 hrs 
if necessary in combination with 
Mygale comp. dil. WELEDA, 5–10 drops every 1–2 hrs

Gesellschaft Anthroposophischer Ärzte in Deutschland/GAÄD, Medizinische Sektion am Goetheanum (Hg.) Vademecum Anthroposophische Arzneimittel. 4. Aufl. München 2017. www.vademecum.org

Debus M. Medikamentöse Begleitbehandlung bei onkologischen Erkrankungen. Der Merkurstab 2009;62(4):320-325.



Research news

Real World Data Study: Factors Associated with Self-Reported Post/Long-COVID    
Little evidence exists on the risk factors that contribute to Post/Long-COVID (PLC). In a recent prospective study, 99 registered people reported suffering from PLC symptoms - most commonly from fatigue, dyspnea, decreased strenght, hyposmia, and memory loss. The study results show, for example, that people, who suffered from COVID-19-associated anxiety, hyposmia, or palpitations were up to eight times more at risk of developing PLC than people without these symptoms. Individuals who suffered from fatigue during COVID-19 treatment were seven times more at risk to develop PLC fatigue than those who did not show this symptom. Overall, the results revealed that 13% of the study participants who had previously suffered from COVID-19 subsequently reported having PLC. The article is published open access: 
https://doi.org/10.3390/ijerph192316124.


Further information on Anthroposophic Medicine